Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

318 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oncologic Outcomes of Patients with Immune Checkpoint Inhibitor Resistant Urothelial Carcinoma Treated with Enfortumab Vedotin and the Impact of Neutrophil-to-Lymphocyte Ratio and Dysgeusia on Overall Survival: A Retrospective Multicenter Cohort Study in Japan.
Nakane K, Taniguchi K, Nezasa M, Enomoto T, Yamada T, Tomioka-Inagawa R, Niwa K, Tomioka M, Ishida T, Nagai S, Yokoi S, Taniguchi T, Kawase M, Kawase K, Iinuma K, Tobisawa Y, Koie T. Nakane K, et al. Among authors: koie t. Cancers (Basel). 2024 Jul 25;16(15):2648. doi: 10.3390/cancers16152648. Cancers (Basel). 2024. PMID: 39123376 Free PMC article.
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy.
Koie T, Mitsuzuka K, Yoneyama T, Narita S, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C, Yoneyama T, Tobisawa Y. Koie T, et al. Int J Clin Oncol. 2015 Feb;20(1):176-81. doi: 10.1007/s10147-014-0696-0. Epub 2014 Apr 29. Int J Clin Oncol. 2015. PMID: 24771079
Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.
Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y. Koie T, et al. World J Surg Oncol. 2014 Apr 30;12:134. doi: 10.1186/1477-7819-12-134. World J Surg Oncol. 2014. PMID: 24885947 Free PMC article.
Testicular metastasis of prostate cancer: a case report.
Kusaka A, Koie T, Yamamoto H, Hamano I, Yoneyama T, Hashimoto Y, Ohyama C, Tobisawa Y, Yoneyama T. Kusaka A, et al. Among authors: koie t. Case Rep Oncol. 2014 Sep 18;7(3):643-7. doi: 10.1159/000367779. eCollection 2014 Sep. Case Rep Oncol. 2014. PMID: 25408658 Free PMC article.
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
Koie T, Ohyama C, Hatakeyama S, Imai A, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Hosogoe S, Yamamoto H, Kitayama M, Hirota K. Koie T, et al. Int J Clin Oncol. 2016 Apr;21(2):379-383. doi: 10.1007/s10147-015-0880-x. Epub 2015 Jul 30. Int J Clin Oncol. 2016. PMID: 26223693
318 results